|
|
Volumn 25, Issue 12, 2001, Pages 967-973
|
|
Immunoglobulin treatment versus plasma exchange in patients with chronic moderate to severe myasthenia gravis
a
|
|
Author keywords
Immunoglobulin controlled crossover study; Myasthenia gravis; Plasma exchange
|
|
Indexed keywords
PATIENT TREATMENT;
A-STABLE;
AFTER-TREATMENT;
FOLLOW UP;
HIGH DOSE;
IMMUNOGLOBULIN-CONTROLED CROSSOVER STUDY;
MYASTHENIA GRAVIS;
PATIENT'S SUFFERING;
PLASMA EXCHANGES;
STABLE PHASIS;
STATISTICAL SIGNIFICANCE;
DISEASES;
AZATHIOPRINE;
IMMUNOGLOBULIN;
PREDNISONE;
PYRIDOSTIGMINE;
ADULT;
AGED;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DISEASE SEVERITY;
DRUG EFFICACY;
DRUG MEGADOSE;
FEMALE;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
INTERMETHOD COMPARISON;
MALE;
MYASTHENIA GRAVIS;
PLASMAPHERESIS;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RATING SCALE;
SYMPTOM;
TREATMENT OUTCOME;
|
|
EID: 0035698077
PISSN: 0160564X
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1525-1594.2001.06717.x Document Type: Article |
|
Times cited : (110)
|
|
References (15)
|
